Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIME: Everolimus vs Cyclosporin in de Novo Renal Transplant
NCT01595984Phase 3Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- May 2012
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in kidney failure (ESRD), sponsored by CHU Amiens-Picardie. Started May 2012; status: completed.
02
Drugs
everolimus
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT01595984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595984.